Treatment of Multiple Sclerosis Using Over the Counter Inosine
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether raising low levels of the natural
antioxidant uric acid by the administration of a precursor, inosine, has any therapeutic
effect on the progression of Relapsing Remitting Multiple Sclerosis (RRMS) and secondary
progressive Multiple Sclerosis (MS).
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)